Loading
Latest filing published 30 Sept 2024 for Pressure Biosciences INC, €361.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Michael S. Urdea on record concern Pressure Biosciences Inc, in the capacity of board member. We count 28 filings; the first trade dates from 22 November 2017 and the latest from 27 September 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 30 September 2024, reports a transaction of €361 in Pressure Biosciences Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations